Verified questions
For 2026 application planning, founders should focus on the questions that reveal fit, judgment, and program-specific leverage:
What medical technology or device are you developing?
Why they ask this: ZeroTo510 needs precision because medtech applications cannot stay at the level of broad healthcare ambition. The first question establishes what is being built, who it helps, and what category of device risk reviewers are evaluating.
What a good answer looks like: Describe the device or technology in plain clinical and product terms. Include the user, setting, and patient or workflow problem without burying the answer in jargon.
What evidence supports technical feasibility and market need?
Why they ask this: This question separates interesting science from a fundable medical product. Reviewers need to know whether the technology can work and whether clinicians, patients, payers, or health systems have a reason to care.
What a good answer looks like: Use prototype evidence, clinical insight, customer discovery, letters of support, pilot signals, or technical validation. Explain both feasibility and demand; one without the other is weaker.
What regulatory, reimbursement, or clinical study questions do you need to resolve?
Why they ask this: Medtech progress depends on more than prototype quality. ZeroTo510 asks this to see whether the founder understands FDA pathway, clinical evidence, coding, payment, and study-design risk.
What a good answer looks like: Name the unresolved questions honestly and show how you plan to answer them. A strong answer is serious about regulation and reimbursement without pretending every detail is solved.
How would a 90-day medtech accelerator change your go-to-market plan?
Why they ask this: The 90-day framing tests whether the accelerator can create a real shift in validation, commercialization, or Investor readiness. It also shows whether the founder can focus under time pressure.
What a good answer looks like: Pick a practical go-to-market improvement for the program window. Good answers tie mentor input, clinical access, regulatory planning, or Investor preparation to a concrete outcome.
Source checked from ZeroTo510 source material. Application pages can change, so treat this as verified preparation material, not a substitute for the final form.